Visual Inspection of Parenterals: Defects and Records

Last reviewed 12 Nov 2026 · 8 min read

Contents
  1. What visual inspection is meant to find
  2. Defect categories are product and process specific
  3. Manual and automated inspection controls
  4. Manual inspection
  5. Automated inspection
  6. A practical batch workflow
  7. Inspection record template
  8. Common mistakes
  9. Fictional example
  10. Frequently asked questions
  11. Are critical, major and minor defect classes universal?
  12. How often do manual inspectors need qualification?
  13. Can automated inspection replace manual inspection?
  14. Does visual inspection confirm the container seal is intact?
  15. Related reading
  16. References

In short: Visual inspection checks parenteral containers for visible particles and other defects that may affect product quality or patient safety. The defect library, classification rules and inspection controls should be qualified for the product and process. Record the outcome by defect type and review trends; a visual check does not replace container-closure integrity testing or a separate subvisible-particle method.

What visual inspection is meant to find

Visual inspection is a quality control step for filled injectable containers. The reviewer looks for visible extraneous matter and other container or product defects using a controlled manual process or a qualified automated system. The product, formulation, container material, fill level and particle characteristics can all affect what an inspector can see.

USP General Chapter <790>, Visible Particulates in Injections, states that products intended for parenteral administration are visually inspected for particulate matter as specified in USP <1>. USP General Chapter <1790>, Visual Inspection of Injections, explains that detection is probabilistic: the chance of detecting a particle varies with particle size, shape, colour and density, dosage form and container design. The chapter also discusses difficult-to-inspect products. These points matter when setting qualification challenges and interpreting inspection results.

For EU GMP, Annex 1 (2022), paragraphs 8.30–8.33, says filled parenteral containers should be inspected individually for extraneous contamination or other defects. It directs manufacturers to define defect classification and criticality during qualification, using risk and historical knowledge, maintain a defect library, control manual inspection conditions and rates, validate automated inspection, and record and trend outcomes. The Annex became operational on 25 August 2023, with point 8.123 postponed to 25 August 2024.

Defect categories are product and process specific

There is no universal table that assigns every visible flaw to the same severity class for every injectable. A crack, foreign particle, seal concern, cosmetic mark or fill appearance may have different significance depending on container type, route of administration, product properties and the approved specification. Define category names, examples, decision rules and escalation paths in the site’s qualified defect library.

The following framework is an example for discussion only. Example in-house criterion (not a pharmacopoeial requirement): use a site-defined critical/major/minor scale after a documented risk assessment, with the final decision rules approved in the quality system.

Site-defined categoryQuestions for risk assessmentPossible follow-up
CriticalCould the condition create a serious patient risk, compromise the container, or indicate contamination? Is the route or dose especially sensitive?Reject the unit under the approved criteria; assess the batch and open an investigation where required.
MajorCould the defect affect product identification, usability, dose delivery, appearance specified for the product or container protection?Apply the approved rejection rule and assess whether similar units or process conditions are affected.
MinorIs the condition cosmetic and demonstrably without impact on identity, strength, quality, purity, safety or use?Record and trend according to the site criteria; do not downgrade a defect without documented rationale.

These labels should not be copied as ready-made limits. Annex 1 specifically places the classification and criticality decision in qualification and calls for risk and historical knowledge. Examples should be drawn from actual container and product risks, with representative samples in the defect library.

Manual and automated inspection controls

Manual inspection

EU GMP Annex 1 §8.31 calls for suitable, controlled illumination and background, qualified inspection rates and visual-inspection qualification for operators at least annually. Qualification uses appropriate defect-library samples and considers worst-case factors such as inspection time, line speed, container size and fatigue. It should also consider eyesight checks and use of corrective lenses where normally worn. Minimise distractions and provide suitable breaks.

The exact workstation, handling steps, rest period, light checks and qualification challenge should be defined in the approved procedure. Avoid copying another site’s values without showing that they suit the product and container. Training should include both acceptable units and representative defect samples, so operators learn the decision rules rather than only the appearance of a reject.

Automated inspection

Under Annex 1 §8.32, an automated process should be validated to detect known defects that can affect product quality or safety, and should perform at least as well as the manual inspection method. Challenge the equipment with representative defects before start-up and at regular intervals throughout the batch. Define how the system handles alarms, rejected units, reinspection and any manual review of uncertain results.

Visual inspection is not a container-closure integrity test. Annex 1 §8.22 explicitly says visual inspection is not an acceptable integrity test method for sealed containers. It also does not replace separate subvisible-particle testing where that is required by the applicable product standard or specification.

A practical batch workflow

  1. Confirm scope and instructions. Verify product, batch, container type, presentation, applicable specification and the approved inspection procedure. Confirm whether inspection is manual, automated or a defined combination.
  2. Verify readiness. Check the inspection area, equipment status and approved inspection conditions. Confirm the operator is currently qualified or that the automated system is released for use.
  3. Inspect each filled container. Use the handling sequence and viewing conditions defined in the procedure. For manual inspection, maintain the qualified rate and controlled background. For automated inspection, follow validated system settings and challenge requirements.
  4. Sort and record defect findings. Use the defect library and site decision rules. Record the defect type and category rather than using a vague entry such as “bad unit.” Preserve representative samples or images where the procedure requires them.
  5. Reconcile accepted, rejected and unresolved units. Follow the approved process for rejects, reinspection and equipment alarms. Never return a unit to the acceptable population just because a second look is inconclusive; use the established disposition rule.
  6. Review trends and exceptions. Compare defect types and counts with routine process history. Annex 1 §8.30 calls for investigating unusual defect levels, and §8.33 calls for trending defect types, counts and reject levels using statistical principles.
  7. Assess impact and close the record. Investigate adverse trends or a critical defect found after inspection. Assess whether other units or product already on the market may be affected, and document the authorised disposition and corrective actions.

Inspection record template

This blank table is a practical starting point for a controlled batch record. Site procedures should align it with the approved specification and inspection process.

Record fieldEntry
Product, strength, batch and expiry
Container and closure presentation
Inspection method, equipment and procedure version
Inspection date, shift and operator or system identifier
Operator qualification or equipment release reference
Defect-library version and defect categories used
Units inspected and disposition by defect type
Reinspection, alarms, deviations and investigation references
Trend review and batch impact assessment
Reviewer, quality decision and date

For batch documentation, retain records at least one year after expiry of the respective product batch. EU GMP Volume 4 Chapter 4 §4.11 specifies the longer of one year after expiry or five years after Qualified Person certification; 21 CFR 211.180(a) sets at least one year after expiry for applicable US drug-product records. Follow any longer product-specific or local requirement.

Common mistakes

  • Using a generic defect chart: Apply a qualified defect library that reflects the actual product, presentation and route.
  • Treating every particle as the same: Particle identity, size, shape, density and context affect risk and detectability. Do not make a disposition from appearance alone when the procedure calls for investigation or identification.
  • Relying on an occasional sample check: The EU Annex 1 individual-inspection expectation applies to filled parenteral containers. Sampling after the fact is not a substitute for the defined inspection process.
  • Changing the inspection rate informally: Manual rates should be controlled and qualified. A faster line can change detection performance and fatigue risk.
  • Using visual inspection to claim closure integrity: Use the validated integrity test method where required; visual appearance alone does not establish a seal.
  • Recording only the overall reject percentage: A total hides changes in specific defect modes. Record type and numbers, then review trends.
  • Ignoring late critical defects: Annex 1 says a critical defect found during later sampling of acceptable containers should trigger an investigation of the original inspection process.

Fictional example

During inspection of a glass injectable batch, an operator finds a container with an irregular visible particle and records the defect using the qualified library category. The unit is rejected under the approved procedure. Quality reviews the batch’s particle-related findings and compares them with routine process trends. If the count or pattern is unusual, the team investigates possible sources such as components, equipment, handling and the filling process, then assesses whether other batches or distributed product could be affected. The record preserves both the individual finding and the batch-level decision.

Frequently asked questions

Are critical, major and minor defect classes universal?

No. EU GMP Annex 1 §8.30 requires the classification and criticality to be determined during qualification using risk and historical knowledge. A site’s category definitions should be justified and controlled.

How often do manual inspectors need qualification?

EU GMP Annex 1 §8.31 says operators should undergo visual-inspection qualification at least annually. The qualification should use the defect library and consider relevant worst-case conditions.

Can automated inspection replace manual inspection?

Automated inspection may be used when validated to detect known relevant defects and shown to be at least as effective as the manual method, as described in Annex 1 §8.32. The site still needs controls for equipment performance, challenges and result review.

Does visual inspection confirm the container seal is intact?

No. Annex 1 §8.22 states that visual inspection is not an acceptable container-closure integrity test method. Use the applicable validated integrity test.

References

Related articles